CANCER FUND

Overview

CANCER FUND is a private investment firm dedicated to accelerating the development and commercialization of innovative cancer therapies, diagnostics, and prevention methods. By investing in early-stage companies, they aim to improve patient outcomes, increase access to care, and reduce treatment costs. Their portfolio spans various sectors within the healthcare industry, including biotechnology, medical devices, diagnostics, and pharmaceuticals. The firm employs a community-driven six-step investment process, engaging over 10,000 physicians, researchers, cancer survivors, patients, and their families in selecting and supporting promising cancer innovations. This collaborative approach ensures that investments align with both financial objectives and the broader mission of enhancing cancer care. CANCER FUND's commitment to transparency and community involvement distinguishes it in the impact investment landscape. By combining financial support with active participation from a diverse community, they strive to bring groundbreaking cancer solutions to market more effectively and efficiently.

Investment Focus

• Innovative cancer therapies
• Early-stage companies
• Potential for significant impact on patient outcomes

Portfolio Companies